Dutasteride, a brand name used under the brand name Avodart, is a drug used primarily to treat the symptoms of enlarged prostate. It may take a few months before the benefits accrue
Anant Labs manufacture and furnish high quality Dutasteride impurities for global markets. Our Dutasteride EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
Dutasteride164656-23-9AvodartAvolveGG-745DuastrideGI-198745GI 198745GG 745DutasteridaDTXSID8046452(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamideO0J6XJN02INSC-740477(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamidealpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidideNSC-759880DTXCID6026452CHEBI:521033JALYN COMPONENT DUTASTERIDEN-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide(1S,2R,7R,10S,11S,14S,15S)-N-[2,5-bis(trifluoromethyl)phenyl]-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-ene-14-carboxamideGG745dutasteridumN-(2,5-bis(trifluoromethyl)phenyl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide(1S,2R,7R,10S,11S,14S,15S)-N-(2,5-bis(trifluoromethyl)phenyl)-2,15-dimethyl-5-oxo-6-azatetracyclo(8.7.0.0^(2,7).0^(11,15))heptadec-3-ene-14-carboxamide(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-(2,5-bis(trifluoromethyl)phenyl)-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno(5,4-f)quinoline-1-carboxamide(5alpha,17beta)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-azaandrost-1-ene-17-carboxamide745, GGRefChem:57229G04CB0217beta-N-(2,5-bis(trifluoromethyl))phenyl-carbamoyl-4-aza-5alpha-androst-1-en-3-oneAvolve,(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamideDuagenC27H30F6N2O2MFCD009378691H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(2,5-Bis(trifluoromethyl)phenyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamideCHEMBL1200969(1S,3aS,3bS,5aR,9aR,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamideDutasteride [USAN](5alpha,17beta)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4- Aza -androst-1-ene-17-carboxamideAvodart (TN)UNII-O0J6XJN02IDutasteridAvidartDuprostGI198745Dutasteride [USAN:INN:BAN]Avidart;Avodart;Dutagen;Dutasteride CRSAvolve;Duagen;Dutas;NCGC00164571-01(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-Bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide1H-Indeno(5,4-f)quinoline-7-carboxamide, N-(2,5-bis(trifluoromethyl)phenyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-GI-198745XDutasteride (Standard)DUTASTERIDE [MI]DUTASTERIDE [INN]DUTASTERIDE [JAN]DUTASTERIDE [VANDF]SCHEMBL5903DUTASTERIDE [MART.]DUTASTERIDE [USP-RS]DUTASTERIDE [WHO-DD]Dutasteride (JAN/USP/INN)GTPL7457orb1308434Dutasteride - Bio-X trade markSCHEMBL29454739Dutasteride, >=98% (HPLC)DUTASTERIDE [ORANGE BOOK]DUTASTERIDE [EP MONOGRAPH]GLXC-06659DUTASTERIDE [USP MONOGRAPH]EX-A1952MSK15349Tox21_112199BDBM50340481EBC-11281HY-13613RNSC740477s1202AKOS015920136AKOS015924431Dutasteride for system suitability CRSMSK15349-100ACCG-269904CS-1542DB01126FD22629GS-3565MSK15349-1000ANSC 740477NSC 759880(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-1H,2H,4aH,4bH,5H,6H,6aH,7H,8H,9H,9aH,9bH,10H,11H,11aH-indeno[5,4-f]quinoline-7-carboxamideBD164398HY-13613CAS-164656-23-9D5973D8276D03820Dutasteride Solution in Acetonitrile, 100ug/mLEN300-124223AB01274774-01AB01274774_02Dutasteride Solution in Acetonitrile, 1000ug/mLQ424760BRD-K30373883-001-02-8Z1558504346Dutasteride, European Pharmacopoeia (EP) Reference StandardDutasteride, United States Pharmacopeia (USP) Reference StandardDutasteride for system suitability, European Pharmacopoeia (EP) Reference Standard(4ar,4bs,6as,7s,9as,9bs,11ar)-n-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1h-indeno[5,4-f]quinoline-7-carboxamide(5.ALPHA.,17.BETA.)-N-(2,5-BIS(TRIFLUOROMETHYL)PHENYL)-3-OXO-4-AZAANDROST-1-ENE-17-CARBOXAMIDE(5.alpha.,5 bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide;dutasteride;Avodart;(5|_,17|_)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4- Aza -androst-1-ene-17-carboxamide(5alpha,17beta)-N-{2,5-bis(trifluoromethyl)-phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide.ALPHA.,.ALPHA.,.ALPHA.,.ALPHA.',.ALPHA.',.ALPHA.'-HEXAFLUORO-3-OXO-4-AZA-5.ALPHA.-ANDROST-1-ENE-17.BETA.-CARBOXY-2',5'-XYLIDIDE
